Note 3 - Notes Receivable
|6 Months Ended|
Jun. 30, 2017
|Notes to Financial Statements|
|Loans, Notes, Trade and Other Receivables Disclosure [Text Block]||
July 2012,the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a
$90,000unsecured promissory note. The note bore interest at
6%per annum for
fifty-fourmonths and required monthly principal and interest payments over
forty-twomonths, beginning on
August 2013.The note matured in
January 2017and was paid in full upon maturity.
July 2015,the Company entered into
twolicense transfer agreements, in exchange for
$29,925in separate unsecured promissory notes. The non-interest bearing notes require monthly principal payments over
24months, beginning on
September 1, 2015and maturing on
August 1, 2017.
May 2016,the Company entered into
threelicense transfer agreements, in exchange for
$7,500unsecured promissory notes. The non-interest bearing notes require monthly principal payments over
sixmonths, beginning on
May 1, 2017and maturing on
October 1, 2017.
April 29, 2017,the Company entered into a regional developer agreement for certain territories in the state of Florida in exchange for
$187,000was funded through a promissory note. The note bears interest at
10%per annum for
42months and requires monthly principal and interest payments over
November 1, 2017and maturing on
October 1, 2020.
The net outstanding balance of the notes as of
June 30, 2017and
December 31, 2016were
The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.
Reference 1: http://www.xbrl.org/2003/role/presentationRef